Related Experiment Video
Updated: Apr 3, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Challenges and solutions to implementing drug-resistant tuberculosis programmes for children in Central Asia
P du Cros1, A Swaminathan2, O I Bobokhojaev3
1Manson Unit, Médecins Sans Frontières (MSF), London, UK.
Establishing pediatric drug-resistant tuberculosis (DR-TB) services requires a structured framework for national tuberculosis programs (NTPs). This study outlines challenges and solutions for implementing pediatric DR-TB care in resource-limited settings.
Area of Science:
- Public Health
- Infectious Diseases
- Pediatrics
Background:
- Existing guidelines for pediatric drug-resistant tuberculosis (DR-TB) primarily focus on individual patient care, lacking comprehensive strategies for national tuberculosis programs (NTPs).
- There is a significant gap in guidance for NTPs on planning, implementing, and integrating DR-TB services specifically for children.
- The Tajikistan Ministry of Health and Médecins Sans Frontières initiated a pediatric TB program in 2011, leading to the first MDR-TB treatments for children in 2013.
Purpose of the Study:
- To describe the challenges and solutions encountered in establishing a pediatric DR-TB care program in Tajikistan.
- To propose a framework to guide the implementation of pediatric DR-TB services.
- To offer a model for NTPs in resource-limited settings to develop their own pediatric DR-TB care strategies.
Main Methods:
- Case study description of a pediatric tuberculosis program in Tajikistan.
- Analysis of challenges faced during program establishment and implementation.
- Development of a proposed framework for pediatric DR-TB care.
Main Results:
- The Tajikistan program successfully initiated treatment for 21 children with multidrug-resistant tuberculosis (MDR-TB).
- Key challenges in establishing the program were identified and addressed.
- A framework for implementing pediatric DR-TB care was developed based on program experiences.
Conclusions:
- Implementing pediatric DR-TB care presents unique challenges, particularly in resource-limited settings.
- A structured framework is essential for NTPs to effectively plan and deliver DR-TB services for children.
- The proposed framework can assist other NTPs in developing and improving their pediatric DR-TB programs.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

